Current position:Home >Product >
1,2-Cyclopentanediol, 5-(6-amino-9H-purin-9-yl)-3-(hydroxymethyl)-1-methyl-4-methylene-, (1R,2S,3S,5S)-rel-
1,2-Cyclopentanediol, 5-(6-amino-9H-purin-9-yl)-3-(hydroxymethyl)-1-methyl-4-methylene-, (1R,2S,3S,5S)-rel-(636582-98-4)
- Name: 1,2-Cyclopentanediol, 5-(6-amino-9H-purin-9-yl)-3-(hydroxymethyl)-1-methyl-4-methylene-, (1R,2S,3S,5S)-rel-
- Synonyms:
- Molecular Formula:C13H17N5O3
- Molecular Weight:
- CAS Registry Number:636582-98-4
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 63657-95-4/1-Cyclodecene-1-carboxylic acid, (E)-
- 63657-96-5/1-Cycloundecene-1-carboxylic acid, (E)-
- 63657-97-6/1-Cyclododecene-1-carboxylic acid, (E)-
- 636582-91-7/4H-Pyrrolo[2,3-d]pyrimidin-4-one, 2-amino-7-[(1R,2S,3R,4R)-2,3-dihydroxy-4-(hydroxymethyl)-2-methyl-5- methylenecyclopentyl]-1,7-dihydro-, rel-
- 636582-92-8/4H-Pyrrolo[2,3-d]pyrimidin-4-one, 2-amino-7-[(1R,2S,3R,4R)-2,3-dihydroxy-4-(hydroxymethyl)-2-methyl-5- methylenecyclopentyl]-1,7-dihydro-
- 636582-93-9/1,2-Cyclopentanediol, 5-(4-amino-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-3-(hydroxymethyl)-1-methyl- 4-methylene-, (1R,2S,3S,5S)-rel-
- 636582-94-0/1,2-Cyclopentanediol, 5-(4-amino-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-3-(hydroxymethyl)-1-methyl- 4-methylene-, (1S,2R,3R,5R)-
- 636582-97-3/1,2-Cyclopentanediol, 5-(6-amino-9H-purin-9-yl)-3-(hydroxymethyl)-1-methyl-4-methylene-, (1S,2R,3R,5R)-
- 636582-98-4/1,2-Cyclopentanediol, 5-(6-amino-9H-purin-9-yl)-3-(hydroxymethyl)-1-methyl-4-methylene-, (1R,2S,3S,5S)-rel-
- 636582-99-5/1,2-Cyclopentanediol, 5-(4-amino-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-3-(hydroxymethyl)-1-methyl- , (2R,3R,5R)-
- 636583-00-1/1,2-Cyclopentanediol, 5-(4-amino-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-3-(hydroxymethyl)-1-methyl- , (1S,2R,3R,5R)-
- 636583-01-2/1,2-Cyclopentanediol, 5-(6-amino-9H-purin-9-yl)-3-(hydroxymethyl)-1-methyl-, (2R,3R,5R)-
- 636583-02-3/1,2-Cyclopentanediol, 5-(6-amino-9H-purin-9-yl)-3-(hydroxymethyl)-1-methyl-, (1S,2R,3R,5R)-
- 636583-11-4/Triphosphoric acid, P-[[(1R,2R,3S,4R)-4-(1,6-dihydro-6-oxo-9H-purin-9-yl)-2,3-dihydroxy-3- methyl-5-methylenecyclopentyl]methyl] ester
- 636583-13-6/Triphosphoric acid, P-[[(1R,2R,3S,4R)-4-(6-amino-9H-purin-9-yl)-2,3-dihydroxy-3-methyl-5- methylenecyclopentyl]methyl] ester
- 636583-14-7/Triphosphoric acid, P-[[(1R,2R,3S,4R)-4-(6-amino-9H-purin-9-yl)-2,3-dihydroxy-3-methyl-5- methylenecyclopentyl]methyl] ester, rel-
- 636583-23-8/Cyclopentanol, 2-(2-amino-4-chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-5-[(4-methoxyphen yl)diphenylmethoxy]-3-methylene-4-[(phenylmethoxy)methyl]-, (1R,2S,4S,5S)-rel-
- 636583-25-0/1,2-Cyclopentanediol, 5-(4-amino-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-3-(hydroxymethyl)-1-methyl- , (1R,2R,3R,5R)-
- 636583-26-1/1,2-Cyclopentanediol, 3-[[6-chloro-5-(2,2-diethoxyethyl)-4-pyrimidinyl]amino]-5-(hydroxymethyl) -, (1R,2S,3R,5R)-
- 636583-27-2/1,2-Cyclopentanediol, 3-(4-chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-5-(hydroxymethyl)-, (1R,2S,3R,5R)-
- 636583-32-9/1,2-Cyclopentanediol, 5-(4-chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-3-(hydroxymethyl)-1-methyl- , (1R,2R,3R,5R)-
- 636583-33-0/1,2-Cyclopentanediol, 5-(4-chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-3-(hydroxymethyl)-1-methyl- , (1S,2R,3R,5R)-
- 636583-51-2/Stannane, tributyl[4-methyl-1-[(phenylmethoxy)methoxy]pentyl]-
- 636583-59-0/10-Octacosen-1-ol
- 636583-85-2/6-Oxabicyclo[3.1.0]hexane-2,4-diol, 3-[(phenylmethoxy)methyl]-, (2R,4S)-rel-
- 636583-86-3/6-Oxabicyclo[3.1.0]hexan-2-ol, 4-[(4-methoxyphenyl)diphenylmethoxy]-3-[(phenylmethoxy)methyl]-, (2R,3R,4S)-rel-
- 636583-87-4/6-Oxabicyclo[3.1.0]hexan-2-one, 4-[(4-methoxyphenyl)diphenylmethoxy]-3-[(phenylmethoxy)methyl]-, (3R,4R)-rel-
- 636583-88-5/6-Oxabicyclo[3.1.0]hexane, 2-[(4-methoxyphenyl)diphenylmethoxy]-4-methylene-3-[(phenylmethoxy) methyl]-, (2R,3R)-rel-
- 636582-09-7/Pyridazine, 3-(2,4-dibromophenoxy)-6-ethoxy-
- 636582-08-6/Pyridazine, 3-(3-bromophenoxy)-6-ethoxy-